Lu Jin Electronics is the largest PCB supplier of Xu Antai Medicine. In Contemporary Ampere Technology Co., Ltd., it is mainly engaged in the research and development of generic drugs.

Cailian reported in August 16 that there are two new shares subscribed today, namely Lu Jin Electronics on the Growth Enterprise Market and Xu Antai Medicine on the Science and Technology Innovation Board; Two new shares are listed, namely Kaigl Seiki of GEM and Haizheng raw material of Science and Technology Innovation Board.

Subscribe for new shares today

Lu Jin Electronics is the largest PCB supplier of Contemporary Ampere Technology Co., Ltd., focusing on the automotive PCB market. Its products cover all the core components and supporting facilities of traditional (fuel) automobile parts and new energy vehicles. 20 16 10, the company became the qualified PCB supplier of Contemporary Amp Technology Co., Ltd., the world's largest manufacturer of new energy automobile batteries, and gradually became the largest PCB supplier of Contemporary Amp Technology Co., Ltd. In addition, in the field of communication, the company has direct or terminal well-known customers such as Huawei, ZTE, Fiberhome Communication, Cambridge Science and Technology, Jacky of South China University of Technology, Yisi Technology, Zhong Yi Digital Network and Yilian Network.

20 19-202 1 year, the company realized operating income of 65438+37 million yuan/248 million yuan/508 million yuan respectively; Realized a net profit of RMB 03 million/RMB 40 million/RMB 65438+RMB 65 million, and turned losses into profits in 20 19. It is estimated that the company will realize a net profit of about 654.38+0.65 billion yuan to 654.38+0.75 billion yuan from June to September in 2022, with a year-on-year increase of about 46.7 1% to 55.60%.

Xu Antai Medicine is mainly engaged in the research and development, production and sales of generic drugs and CRO services. The company has been deeply involved in CRO service for many years, and its customers include Gree Pharmaceutical, Yasheng Pharmaceutical, Zaiding Pharmaceutical, Alice, Chen Xin Pharmaceutical and other listed companies, as well as well as well-known domestic and foreign pharmaceutical companies such as Pfizer Puqiang, Haihe Pharmaceutical and Fang Yi Bio.

From 20 19 to 202 1, the company's revenue was 65438+39 million, 3190,000 and 3160,000 respectively. The net profit was 4.638 million, 65.43.8+23.3 million and 65.43.8+34.9 million respectively. It is estimated that the company will achieve an operating income of RMB 2.05-2.10.50 billion from October to September in 2022, down from 1 1.33% to 7.00% year-on-year, and a net profit of RMB 62-63 million, up from the same period of last year./kloc-.

New shares listed today

Kaige Seiki is a leading supplier of solder paste printing equipment in China, mainly engaged in research and development, production, sales and technical support services of automated precision equipment; The main products are solder paste printing equipment, while operating LED packaging equipment, dispensing equipment and flexible automation equipment. The company has entered the supply system of Foxconn, Huawei, Ding Peng Holdings, BYD and other large domestic companies, forming a strong leading edge.

From 20 19 to 202 1, the company realized operating income of 5150,000 yuan/595 million yuan/797 million yuan respectively; The net profit returned to the mother was 49 million yuan/84 million yuan/1.1.200 million yuan, and the compound growth rate of the net profit returned to the mother was 44.43% in three years. The company expects the company's operating income to be 386 million yuan to 402 million yuan in June-June 2022, which is 0.85% to 5.03% higher than that in 20021. After non-deduction, the net profit is 54,876,5438+0.900 yuan to 57,308.900 yuan, which is 0.45% to 5.96% compared with 2026,5438+0.900 yuan in the same period.

Haizheng raw material is a leader in the domestic polylactic acid industry. The company is mainly engaged in research and development, production and sales of polylactic acid. Products mainly include pure polylactic acid, composite modified polylactic acid and primary products, in which the total income of pure polylactic acid and composite modified polylactic acid always accounts for more than 95%. The company has become a supplier of BASF, the international chemical giant, Novamont, the world's leading bioplastics company, and BGF, a famous Korean retail group.

20 19-202 1 year, the company realized operating income of 232 million yuan/263 million yuan/585 million yuan and net profit of100000 yuan/30 million yuan/35 million yuan respectively. It is estimated that the company will achieve a net profit of130,000 yuan to150,000 yuan in the first half of 2022, a year-on-year decrease of 3 1. 16% to 40.33%.

If you want to know more real-time financial news, please follow us.